1. Academic Validation
  2. A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response

A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response

  • Nat Commun. 2026 May 6. doi: 10.1038/s41467-026-72688-y.
Fiona Shilliday # 1 Miguel Gancedo-Rodrigo # 2 Ginto George # 3 Shintaro Aibara 2 Santosh Adhikari 2 Syedah Neha Ashraf 2 Evelyne J Barrey 2 Paolo A Centrella 4 Damian Crowther 2 Paige Dickson 4 Diana Gikunju 4 Marie-Aude Guié 4 John P Guilinger 4 Anders Gunnarsson 5 Heather P Harding 3 Christopher D Hupp 4 Rachael Jetson 4 Anthony D Keefe 4 JeeSoo Monica Kim 6 Richard J Lewis 7 Taiana Maia de Oliveira 2 Jennifer Le-Marshall 4 Usha Narayanan 4 Katherine A Nugai 4 Dušan Petrović 5 Emma Rivers 2 David Ron 3 Daisy Stringfellow 6 Karl Syson 2 Lewis Ward 2 John T S Yeoman 4 Yan Yu 4 Ying Zhang 4 Alisa Zyryanova 3 David J Baker 8 Perla Breccia 6 John E Linley 6
Affiliations

Affiliations

  • 1 Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. [email protected].
  • 2 Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • 3 Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.
  • 4 X-Chem Inc., Waltham, Massachusetts, USA.
  • 5 Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • 6 Neuroscience, R&D, AstraZeneca, Cambridge, UK.
  • 7 Department of Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • 8 Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.
  • # Contributed equally.
Abstract

Eukaryotic initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF), promotes protein synthesis by charging translation initiation factor 2 (eIF2) with GTP. Stress-induced phosphorylation of eIF2 on its α-subunit [eIF2(αP)] inhibits this reaction triggering a protective Integrated Stress Response (ISR). A DNA-encoded chemical library (DEL) screen for modulators of eIF2B, led to the identification of a chemical series that stabilises the inactive state of eIF2B, stimulating the ISR. Cryo-EM of compound-bound eIF2B reveals a conformational switch to the inactive state engaged by eIF2(αP). In cells, compound activity is sensitive to eIF2's phosphorylation state and to a competing eIF2B ligand (ISRIB) that activates the GEF allosterically. These findings establish the feasibility of targeting eIF2B with a drug-like allosteric inhibitor, that serves as an ISR activator (ISRAC), paving the way to explore the therapeutic potential of eIF2B-directed ISR activation.

Figures